Alpha Tau Medical (NASDAQ:DRTSW – Get Free Report) is anticipated to announce its results before the market opens on Thursday, March 5th. Analysts expect the company to announce earnings of ($0.1235) per share for the quarter.
Alpha Tau Medical Stock Up 25.6%
Shares of Alpha Tau Medical stock opened at $1.50 on Thursday. Alpha Tau Medical has a one year low of $0.13 and a one year high of $1.50. The business’s 50 day simple moving average is $0.80 and its two-hundred day simple moving average is $0.49.
About Alpha Tau Medical
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
Featured Articles
- Five stocks we like better than Alpha Tau Medical
- The Next Commodity Crunch (bigger than oil?)
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Read this or regret it forever
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
